FDA Approves 2 Dose Schedule for Trumenba®
The FDA has just revised the dosing schedule for Pfizer’s Serogroup B Meningococcal Vaccine, Trumenba, adding a two-dose option to the previous three-dose approval. The new product label is attached.
If you have specific questions regarding this new label, please contact Pfizer Medical Information at 1-800-438-1985.
If you need help ordering Trumenba for your patients, please call PedsPal at 1-877-923-2233.